Loading Events

Upcoming Events

Events Search and Views Navigation

September 2021

Magnus Corfitzen CEO at Ascelia Pharma will present at HC Andersen Capital

September 27 @ 12:30 - 13:00

Magnus Corfitzen will present Oncoral and the collaboration agreement with Taiho Oncology Inc. https://hcandersencapital.dk/event/ascelia-pharma-oncoral-samarbejde-med-det-amerikansk-baserede-taiho-oncology/  

Find out more »

Chief Medical Officer Carl Bjartmar will present Ascelia Pharma at Aktiespararna in Lund

September 28 @ 11:00 - 11:30
Elite Hotel Ideon, Scheelevägen 27

For more information: Aktiedagen Lund 28 september | Aktiespararna Take the opportunity to ask your questions  by sending a text message to 079-347 98 45 or emailing event@aktiespararna.se. Your questions will be conveyed by the moderator.

Find out more »

Magnus Corfitzen CEO at Ascelia Pharma will present at Erik Penser Bank Orphan Drugs’s Day

September 30 @ 10:05 - 10:45

Magnus Corfitzen will present at the Erik Penser Bank  Orphan Drugs Day.

Find out more »

October 2021

Danske Bank Event Series: Life Science, Launch Phase

October 5 @ 11:00 - 11:45

Ascelia Pharma's CEO Magnus Corfitzen will present at Danske Bank Life Science Event Series.

Find out more »

November 2021

Interim report 9M (January-September 2021)

November 4 @ 08:00

Report will be released at 8.00am CET and conference call at 10.00am CET

Find out more »

Danske Bank’s Winter Seminar

November 30 - December 2
IDA Conference Center

Ascelia Pharma’s CEO Magnus Corfitzen will present at Danske Bank's Winter Seminar.  

Find out more »

February 2022

Full year report 2021 (January-December 2021)

2022-02-10 @ 08:00

Report will be released at 8.00am CET and conference call at 10.00am CET

Find out more »

May 2022

Annual General Meeting 2022

2022-05-05 @ 14:00 - 16:00

Annual General Meeting 2022

Find out more »

Interim Report Q1 2022

2022-05-11 @ 08:00 - 10:00

Report will be released at 08:00am CET and conference call at 10:00am CET

Find out more »

August 2022

Half-year report 2022

2022-08-18 @ 08:00 - 10:00

Report will be released at 08:00am CET and conference call at 10:00am CET

Find out more »
+ Export Events

About us

Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.

Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)

Download our fact sheet: Ascelia Pharma Factsheet Dec 2020

Events